Blockchain Registration Transaction Record

ANGLE PLC announces supplier agreement with AstraZeneca for prostate cancer assay

ANGLE PLC CEO Andrew Newland announces supplier agreement with AstraZeneca to develop prostate cancer assay

ANGLE PLC announces supplier agreement with AstraZeneca for prostate cancer assay

The partnership between ANGLE PLC and AstraZeneca to develop the AR detection assay is significant for the advancement of prostate cancer studies and clinical oncology. This innovative development has the potential to improve the assessment of prostate cancer therapies, ultimately impacting patient care and treatment outcomes.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x18a809cecda24ae363344127fdd2af617aaf08f229189989540f6664e61244ec
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintlineBpU8-1b8afd3ab375e637da497c8f881be4c8